The benefits of other treatments than in vitro fertilization to aid conception in minimal and mild endometriosis.

Minerva ginecologica · 2016 · vol. 68(6) , pp. 675–86 · PMID:27077394 · W2410672923
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed

Abstract

The treatment of minimal or mild endometriosis prior to non-in-vitro fertilization (IVF) assisted reproduction to improve pregnancy outcomes is controversial. Ovulation suppression may be offered to women who do not wish to conceive to suppress advancement of the disease. There is little evidence to suggest improvements in fertility associated ovarian suppression prior to non-IVF infertility treatments. The use of intrauterine insemination without ovulation induction offers little benefit, with low pregnancy rates in most studies. Surgical ablation seems to improve outcomes when other care will not be delivered. Although controversial, surgical ablation before ovulation induction may offer benefit but further studies would be helpful. Ovulation induction seems to increase pregnancy rates and either letrozole or clomiphene citrate should be considered as first line options. If pregnancy does not occur with three months of ovulation induction, based on dropping success rates with further cycles of ovarian stimulation, IVF should be offered.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Endometriosis Infertility, Female Reproductive Techniques, Assisted Clomiphene Clomiphene Endometriosis Endometriosis Endometriosis Female Fertility Agents, Female Fertility Agents, Female Fertilization in Vitro Humans Infertility, Female Letrozole Nitriles Nitriles Ovulation Induction Ovulation Induction Pregnancy

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

europepmc
last seen: 2026-06-12T06:13:51.797165+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:21:07.355239+00:00
License: CC0 · commercial use OK